6533b851fe1ef96bd12a9080

RESEARCH PRODUCT

Changes in life expectancy for cancer patients over time since diagnosis

L. BottaL. Dal MasoS. GuzzinatiC. PanatoG. GattaA. TramaM. RuggeG. TagliabueC. CasellaB. CarusoM. MichiaraS. FerrettiF. SensiR. TuminoF. ToffoluttiA. G. RussoA. L. CaiazzoL. MangoneW. MazzuccoS. IacovacciP. RicciG. GolaG. CandelaA. S. SardoR. De AngelisC. BuzzoniR. Capocaccia Airtum Working Group

subject

0301 basic medicinePediatricsmedicine.medical_specialtycancer survivorLife expectancyCancer survivorsPopulationYLL years of life lost(ICD-O-3) international classification of diseases for oncology third revisionSocio-culturaleLife expectancy Population-based cancer registry Relative survival Cancer Cancer survivors ItalySettore MED/42 - Igiene Generale E ApplicataRelative survival03 medical and health sciences0302 clinical medicineHealth careMedicineeducationlcsh:Science (General)Population-based cancer registryThyroid cancerCancerRS relative survivaleducation.field_of_studylcsh:R5-920MultidisciplinaryRelative survivalbusiness.industryAbsolute risk reductionCancermedicine.diseaseLE life expectancyNHL non-Hodgkin lymphoma030104 developmental biologyYears of potential life lostItalyISTAT national institute of statistics030220 oncology & carcinogenesisLife expectancy(ICD-10) international classification of diseases tenth revisionOriginal Articlebusinesslcsh:Medicine (General)lcsh:Q1-390

description

Highlights • Research question: how cancer impacts on LE changes during patients’ entire life • LE increased in patients surviving the first years and decreasing thereafter. • Patients’ LE in the end approached but seldom reached the general population’s LE. • This method describes when cancer survivors’ excess risk of death became negligible. • Life expectancy indicator is easy to be understood and interpreted by patients.

10.1016/j.jare.2019.07.002http://europepmc.org/articles/PMC6710558